AbbVie

Open: 174.78 Close: 176.75 Change: 1.97

You'll be sorry if you don't use an AI to decide whether to invest in AbbVie Stock.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, company, CEO, Gonzalez, support, Richard, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

Richard Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, is retiring from the role. He will be replaced by the companys current president and chief operating officer Robert Michael.

Today's News

AbbVie CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday. He will be replaced by the companys current president and chief operating officer Robert Michael. The leadership shakeup comes as Abbvie is contending with new, lower-cost competition. AbbVie agreed to buy cancer drugmaker ImmunoGen for $10.1 billion and biotech company Cerevel in a sale valued at $8.7 billion. I am honored to assume the CEO role for Abbvie, and I am excited about our bright future AbbVie and Tentarix Biotherapeutics announced a collaboration to develop novel biologics in oncology and immunology. TentarIX will receive upfront option payments totaling $64 million for the two programs. Abbvie will receive an exclusive option to acquire the therapeutic programs. AbbVie sells $15 billion of bonds to buy immunogen, cerevel. CEO Michael Gonzalez will become executive chair of the board of directors. The leadership shakeup comes as Abbvie is contending with new, lower-cost competition for its blockbuster autoimmune drug. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. The company has 53,645 employees. AbbVie stock price as of February 4:00:00 PM EST: Abbvie stock rises +161 (+161%) Share Price as of Feb 22:00pm EST. AbbVie supports a strong dividend yield, which should act as valuation support, as the cash flows to support the dividend look secure over the next several years. Richard Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, is retiring from the role. AbbVie Inc. markets open in 8 hours 52 minutes S&P Futures 5,102.75 +5.00 +44.00 (+0.11%) Nasdaq Futures 18,051 +3.50 +1.20 (+1.06%) Crude Oil 78.18 -0.43 (-0.55%) Gold.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, company, CEO, Gonzalez, support, Richard, and the most common words in the summary are: abbvie, bloomberg, market, stock, job, abbvies, company, . One of the sentences in the summary was: He will be replaced by the companys current president and chief operating officer Robert Michael.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #bloomberg #market #stock #job #abbvies #company.